---
type: "Topics"
locale: "en"
url: "https://longbridge.com/en/topics/100000000223630.md"
description: "$Unitedhealth(UNH.US)Restating the 2025 EPS forecast at $16, which aligns with the current share price of $320, resulting in a P/E ratio of 20.I believe this is still quite stable—most of the major risks have been addressed, and the company’s operations have returned to normal. After all, a P/E ratio of 20 for an INDUSTRY LEADER is reasonable and not overpriced.If it weren’t for the recent crisis, the EXPECTED EPS would likely have been around $30. Now that the stock price has bottomed out, if the EPS gradually returns to a normal level, the stock price should follow suit and rise accordingly.Alright then. Let time do its work."
datetime: "2025-09-09T10:36:50.000Z"
locales:
  - [en](https://longbridge.com/en/topics/100000000223630.md)
  - [zh-CN](https://longbridge.com/zh-CN/topics/100000000223630.md)
  - [zh-HK](https://longbridge.com/zh-HK/topics/100000000223630.md)
author: "[Revolution～](https://longbridge.com/en/profiles/16656145.md)"
generator: "portal-rs"
---

# $Unitedhealth(UNH.US)Restating the 2025 EPS foreca…


### Related Stocks

- [UNH.US](https://longbridge.com/en/quote/UNH.US.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**